Overview
Supplied as: Tablet:
800mg,400mg (10's)
Imatinib is a targeted tyrosine kinase inhibitor primarily used to treat various blood cancers and specific solid tumors. Its core indication revolves around cancers driven by abnormal cell growth proteins, most notably the Philadelphia chromosome-positive (Ph+) mutation.